MyFinsight
Home
Blog
About
Contact
Download
Download image
US
$252,185K
(-38.94%↓ Y/Y)
All Other Countries
Other Than Russia...
$168,412K
RU
$100,445K
BR
$65,661K
Collaboration And License
Revenue
$998,357K
Product
$586,703K
Royalty
$244,224K
Total revenues
$1,730,655K
(114.96%↑ Y/Y)
Translarna
-$98,629K
Income (loss) from
operations
$866,935K
(386.52%↑ Y/Y)
Total operating
expenses
$863,720K
(-22.14%↓ Y/Y)
Tangible asset
impairment and (gains)...
$9,627K
(1383.60%↑ Y/Y)
Change in the fair value
of contingent...
$800K
(-82.12%↓ Y/Y)
Income (loss) before
income tax (expense)...
$696,619K
(291.84%↑ Y/Y)
Interest expense, net
-$152,230K
(8.84%↑ Y/Y)
Other (expense)
income, net
-$18,086K
(-376.38%↓ Y/Y)
Research and development
$455,249K
(-14.82%↓ Y/Y)
Selling, general and
administrative
$347,143K
(15.36%↑ Y/Y)
Cost of product,
collaboration and license...
$47,013K
(-18.09%↓ Y/Y)
Amortization of acquired
intangible assets
$24,742K
(-59.26%↓ Y/Y)
Net income (loss)
attributable to common...
$682,644K
(287.90%↑ Y/Y)
Income tax (expense)
benefit
$13,975K
(7840.34%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
PTC THERAPEUTICS, INC. (PTCT)
PTC THERAPEUTICS, INC. (PTCT)